| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/23/2011 | EP1617218B1 METHOD OF SCREENING DRUG WITH THE USE OF 67 kDa LAMININ RECEPTOR |
| 02/23/2011 | EP1448550B1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 02/23/2011 | EP1268096B2 Extrusion die |
| 02/23/2011 | EP1135504B1 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 02/23/2011 | CN1942466B Caspase inhibitors and uses thereof |
| 02/23/2011 | CN1751042B Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 02/23/2011 | CN101981187A Partial peptide of Survivin presented on MHC class II molecule and use thereof |
| 02/23/2011 | CN101980721A Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same |
| 02/23/2011 | CN101980705A Use of benzophenone derivative or salt thereof and TNF alpha inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor |
| 02/23/2011 | CN101980017A Anti-TNF antibodies, compositions, methods and uses |
| 02/23/2011 | CN101979639A Dendrobium polysaccharide with hypoglycemic activity and extracting method thereof |
| 02/23/2011 | CN101979593A Immunotoxin, and preparation method and use thereof |
| 02/23/2011 | CN101979566A Sulpho-oligodeoxynucleotide with immunostimulation activities and application thereof |
| 02/23/2011 | CN101979561A Nucleic acid molecule macrophage inflammatory protein (MIP) 3 alpha antibody to nuclear antigen (ANA) 6 and application thereof to preparation of immunosuppressive medicaments |
| 02/23/2011 | CN101979510A Bone marrow derived neural stem cell for expressing chemotactic factor receptor CCR5 and preparation method thereof |
| 02/23/2011 | CN101979412A IL-18 binding proteins |
| 02/23/2011 | CN101979382A Aminoindazole derivatives and use thereof as kinase inhibitors |
| 02/23/2011 | CN101979095A Treatment and diagnosis of macrophage mediated disease |
| 02/23/2011 | CN101979084A Chinese medicinal composition for warming kidney and tonifying yang and preparation method thereof |
| 02/23/2011 | CN101979057A Medicine for treating anaphylactoid purpura and preparation method thereof |
| 02/23/2011 | CN101979052A Method for establishing high-performance liquid chromatography (HPLC) fingerprint of Guangxi dendrobium candidum wall. ex lindl and standard fingerprint of Guangxi dendrobium candidum wall. ex lindl |
| 02/23/2011 | CN101979030A Chinese medicinal ointment formula and preparation method and application thereof |
| 02/23/2011 | CN101978979A Method for preparing refined celery extract |
| 02/23/2011 | CN101978975A Haematococcus extract preparation, and preparation method and use thereof |
| 02/23/2011 | CN101978974A Method for extracting bioactive substance by breaking walls of chlorella pyrenoidosa chick |
| 02/23/2011 | CN101978969A Method for preparing propolis solution |
| 02/23/2011 | CN101978960A Application of naphthalimide derivative as immunosuppressant |
| 02/23/2011 | CN101978950A Alpha-linolenic acid ester fat emulsion injection and preparation method thereof |
| 02/23/2011 | CN101461919B Medicament composition for treating male climacteric syndrome and delaying age |
| 02/23/2011 | CN101461918B Medicament composition for treating male climacteric syndrome and delaying age |
| 02/22/2011 | US7893280 2,4-disubstituted thiazolyl derivatives |
| 02/22/2011 | US7893279 Cyclohexanecarboxylic acid compound |
| 02/22/2011 | US7893211 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response; immunization; |
| 02/22/2011 | US7893204 Attractin/mahogany-like polypeptides |
| 02/22/2011 | US7893200 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 02/22/2011 | US7893090 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/22/2011 | US7893084 Viral polymerase inhibitors |
| 02/22/2011 | US7893074 inhibition of focal adhesion kinase or/and IGF-1 Receptor; for example: 2-[2-(2,5-Dimethoxy-phenylamino)-5-nitro-pyrimidin-4-ylamino]-N-methyl-benzenesulfonamide |
| 02/22/2011 | US7893071 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic |
| 02/22/2011 | US7893036 In vivo production of small interfering RNAs that mediate gene silencing |
| 02/22/2011 | US7892828 Method of identifying a MHC class I restricted T cell response |
| 02/22/2011 | US7892531 Human serum albumin(HSA); solubilized in low-ionic-strength buffer with specified ph; glycine, aspartic acid, sodium succinate, trehalose; binds with receptors |
| 02/22/2011 | US7892529 Peptides for active anti-cytokine immunization |
| 02/22/2011 | CA2601515C Compounds having immunomodulator activity |
| 02/22/2011 | CA2554195C Peptide originating in epidermal growth factor receptor (egfr) |
| 02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |
| 02/22/2011 | CA2470564C Recombinant polypeptides |
| 02/22/2011 | CA2447712C Herbal drug composition for cartilage protection |
| 02/22/2011 | CA2446314C Liver x receptor agonists |
| 02/22/2011 | CA2410193C Neuronal serine-threonine protein kinase |
| 02/22/2011 | CA2398163C Therapeutic morpholino-substituted compounds |
| 02/22/2011 | CA2329772C Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 02/22/2011 | CA2143491C A novel peptide related to human programmed cell death and dna encoding it |
| 02/17/2011 | WO2011020047A1 Use of il-15 to increase thymic output and to treat lymphopenia |
| 02/17/2011 | WO2011019932A2 Compositions and methods for the therapy and diagnosis of influenza |
| 02/17/2011 | WO2011018858A1 Novel mastitis vaccine |
| 02/17/2011 | WO2011018588A2 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | WO2011018587A2 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | WO2011017998A1 Gambogic acid cyclization analogues, preparation method and application thereof |
| 02/17/2011 | WO2011017909A1 Pharmaceutical solution of cetirizine hydrochloride |
| 02/17/2011 | WO2010111565A3 Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
| 02/17/2011 | WO2009116088A8 Stem cell composition for inducing transplant tolerance |
| 02/17/2011 | US20110041190 Novel chimeric proteins |
| 02/17/2011 | US20110040249 Human Anti-IL-23 Antibodies, Compositions, Methods and Uses |
| 02/17/2011 | US20110040240 Methods for treating rhinitis and conjunctivitis |
| 02/17/2011 | US20110039927 Compositions comprising and processes for producing inorganic salts of hop acids |
| 02/17/2011 | US20110039920 Inhibitors of ikk-beta serine-theronine protein kinase |
| 02/17/2011 | US20110039919 Pharmaceutical compositions for inhibiting angiogenesis |
| 02/17/2011 | US20110039915 IMMUNOSTIMULATORY siRNA MOLECULES |
| 02/17/2011 | US20110039852 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors |
| 02/17/2011 | US20110039851 Ccr10 antagonists |
| 02/17/2011 | US20110039848 Five-membered ring compound |
| 02/17/2011 | US20110039840 Spirocyclic derivatives as histone deacetylase inhibitors |
| 02/17/2011 | US20110039828 Tetrahydroquinoline derivatives and a process for preparing the same |
| 02/17/2011 | US20110039822 Heterocyclic janus kinase 3 inhibitors |
| 02/17/2011 | US20110039819 Substituted phenoxybenzamides |
| 02/17/2011 | US20110039817 4-aminopyrimidine derivatives as histamine h4 receptor antagonists |
| 02/17/2011 | US20110039813 Method of utilization of combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components |
| 02/17/2011 | US20110039791 Acetylcholinesterase (ache)-derived peptide as an inducer of granulocytopoiesis, uses and methods thereof |
| 02/17/2011 | US20110039778 Peptide Synthesis |
| 02/17/2011 | US20110038935 Antibodies against influenza virus and methods of use thereof |
| 02/17/2011 | US20110038903 Apparatus and Process for Generating and Harvesting Adult Stem Cells and Fluid Associated with it from Skin and Omentum for Medical, Cosmetic, and Veterinary Use |
| 02/17/2011 | US20110038900 Nanoparticles for use in pharmaceutical compositions |
| 02/17/2011 | US20110038896 Biodegradable immunomodulatory formulations and methods for use thereof |
| 02/17/2011 | US20110038891 Novel lactic acid bacterium having anti-allergic activity, anti-allergic agent, food and pharmaceutical composition each comprising the lactic acid bacterium, and process for production of the anti-allergic agent |
| 02/17/2011 | US20110038890 Cellular And Viral Inactivation |
| 02/17/2011 | US20110038888 Adjuvant compositions comprising poly-ic and a cationic polymer |
| 02/17/2011 | US20110038885 Chemokine analogs |
| 02/17/2011 | US20110038884 Immunopotentiating agent comprising ep1 agonist |
| 02/17/2011 | US20110038882 Methods for Treating Allergic Disease |
| 02/17/2011 | US20110038881 Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation |
| 02/17/2011 | US20110038879 Immunogenic and therapeutic compositions for streptococcus pyogenes |
| 02/17/2011 | US20110038878 Antibodies to il-17a |
| 02/17/2011 | US20110038869 Monoclonal antibodies against cd32b |
| 02/17/2011 | US20110038866 Improved fibronectin-based binding molecules and uses thereof |
| 02/17/2011 | US20110038860 Methods for inhibition of polyclonal b cell activation and immunoglobulin class switching to pathogenic autoantibodies by blocking cd1-mediated interactions |
| 02/17/2011 | US20110038856 Methods of treating neoplastic, autoimmune and inflammatory diseases |
| 02/17/2011 | US20110038855 Trail and methods of modulating t cell activity and adaptive immune responses using trail |
| 02/17/2011 | US20110038836 Device and Method for Transfecting Cells for Therapeutic Use |
| 02/17/2011 | US20110038801 Methods and compositions for identifying lung cancer or a humoral immune response against lung cancer |